ABSTRACT
We have studied the formation of Pd42.5Cu30Ni7.5P20 metallic glass droplets and wires in the gas atomization process. We demonstrate that the sizes of droplets and wires can be distinguished by the Ohnesorge number (Oh), which is the proportion of the spinnability to the capillary instability, and the diameter distributions follow a log-normal distribution function, implying cascade fragmentation. For droplets, the number significantly increases at Oh < 1 but the diameter gradually decreases. For wires, the number greatly increases at Oh > 1 while the diameter steadies below 400 nm. Further, the wire diameter is quadrupled at Oh = 16 due to the high viscosity which suppresses both capillary breakup and ligament elongation.
ABSTRACT
Our scanning tunneling microscopy and electron diffraction experiments revealed that a new two-dimensional allotrope of Bi forms on the Si(111)-7x7 surface. This pseudocubic [012]-oriented allotrope is stable up to four atomic layers at room temperature. Above this critical thickness, the entire volume of the film starts to transform into a bulk single-crystal (001) phase, as the bulk contribution in the cohesion becomes dominant. Based on ab initio calculations, we propose that the new allotrope consists of black phosphorus-like puckered layers stabilized by saturating all the p(z) dangling bonds in the film.
ABSTRACT
Sporostatin isolated from a fungus of Sporormiella sp.M5032 as an inhibitor of cyclic adenosine 3',5'-monophosphate phosphodiesterase, was found to be a specific inhibitor of epidermal growth factor (EGF) receptor tyrosine kinase in vitro. Its IC50 values were 0.1 microgram/ml (0.38 microM) for EGF receptor kinase, 3 micrograms/ml (11 microM) for ErbB-2, and 100 micrograms/ml (380 microM) or more than that for other kinases including PDGF receptor, v-src and protein kinase C. Kinetic analyses revealed that inhibition of EGF receptor kinase by sporostatin was noncompetitive either with substrate or with ATP. Autophosphorylation of EGF receptor in A431 cells was also inhibited. These results show that sporostatin is a potent and specific inhibitor of EGF receptor kinase.
Subject(s)
Carcinoma, Squamous Cell/pathology , Enzyme Inhibitors/pharmacology , ErbB Receptors/antagonists & inhibitors , Macrolides/pharmacology , Angiotensin II/metabolism , Dose-Response Relationship, Drug , Humans , Inhibitory Concentration 50 , Kinetics , Phosphorylation , Receptor, ErbB-2/metabolism , Receptors, Platelet-Derived Growth Factor/metabolism , Tumor Cells, CulturedABSTRACT
We previously synthesized (6'R)- and (6'S)-6'-C-methylneplanocin A's (2a and 2b, respectively), and found that one of them has a potent antiviral activity, though its 6'-configuration has not been confirmed. This report describes the determination of the 6'-configuration and practical preparation of the antivirally active diastereomer. The 6'-configuration of the active diastereomer was determined as R by the modified Mosher's method as well as by synthesizing 2b from the known cyclopentenone derivative 10. A practical method for preparing the 6'R-diastereomer was developed by using diastereoselective deamination with Ado deaminase as the key step. Treatment of the diastereomeric mixture of 2a and 2b, which was prepared via an addition reaction of Me3Al with the 6'-formyl derivative 3, with Ado deaminase from calf intestine, deaminated 2b selectively to give the corresponding (6'S)-inosine congener 5, and left the desired 2a not deaminated. After silica gel column chromatography, 2a was obtained in a pure form.
Subject(s)
Adenosine Deaminase/chemistry , Adenosine/analogs & derivatives , Antiviral Agents/chemistry , Antiviral Agents/chemical synthesis , Adenosine/chemical synthesis , Adenosine/chemistry , Adenosine/isolation & purification , Chromatography, Gel , Deamination , StereoisomerismSubject(s)
Ascomycota/chemistry , Enzyme Inhibitors/isolation & purification , Macrolides/isolation & purification , Phosphodiesterase Inhibitors/isolation & purification , Animals , Cattle , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Heart/drug effects , Macrolides/chemistry , Myocardium/enzymology , Phosphodiesterase Inhibitors/chemistry , Phosphodiesterase Inhibitors/pharmacologyABSTRACT
The structures of stachybocins A, B and C, new endothelin receptor antagonist, were determined by NMR spectral analysis using pulse-field-gradient technique. Stachybocin A consists of two spirobenzofuran units each fused to a substituted decalin, which were connected by a lysine residue. Stachybocins B and C are derivatives of stachybocin A with an additional hydroxy group at the same position in the different decalin unit.
Subject(s)
Benzofurans/chemistry , Endothelin Receptor Antagonists , Spiro Compounds/chemistry , Stachybotrys/metabolism , Benzofurans/pharmacology , Carbon Isotopes , Magnetic Resonance Spectroscopy , Molecular Structure , Spiro Compounds/pharmacology , TritiumABSTRACT
Stachybocins A, B and C, novel endothelin (ET) receptor antagonists, were isolated from the culture filtrate of Stachybotrys sp. M6222. They were extracted with ethyl acetate and then purified by alumina and silica gel column chromatographies. The molecular formulae of stachybocins were determined to be C52H70N2O10 (stachybocin A) and C52H70N2O11 (stachybocins B and C). It was supposed that they consisted of spirobenzofuran and terpene units from NMR spectra. They showed the inhibitory activity of 125I-ET-1 binding to rate ETA, human ETA and human ETB receptors.
Subject(s)
Benzofurans/pharmacology , Cardiovascular Agents/pharmacology , Endothelin Receptor Antagonists , Spiro Compounds/pharmacology , Stachybotrys/metabolism , Animals , Aorta/drug effects , Aorta/physiology , Benzofurans/chemistry , Benzofurans/isolation & purification , Cardiovascular Agents/chemistry , Cardiovascular Agents/isolation & purification , Cells, Cultured , Endothelins/metabolism , Fermentation , Humans , In Vitro Techniques , Magnetic Resonance Spectroscopy , Male , Mice , Mice, Inbred ICR , Muscle, Smooth, Vascular/cytology , Muscle, Smooth, Vascular/drug effects , Muscle, Smooth, Vascular/physiology , Rabbits , Radioligand Assay , Rats , Receptors, Endothelin/metabolism , Spectrometry, Mass, Fast Atom Bombardment , Spiro Compounds/chemistry , Spiro Compounds/isolation & purification , Vasodilation/drug effectsSubject(s)
Cysteine Endopeptidases , Epoxy Compounds/isolation & purification , Leucine/analogs & derivatives , Protease Inhibitors/isolation & purification , Animals , Cathepsins/antagonists & inhibitors , Cattle , Chemical Phenomena , Chemistry, Physical , Drug Stability , Epoxy Compounds/chemistry , Epoxy Compounds/pharmacology , Humans , Hydrogen-Ion Concentration , Leucine/chemistry , Leucine/isolation & purification , Leucine/pharmacology , Magnetic Resonance Spectroscopy , Mitosporic Fungi/metabolism , Papain/antagonists & inhibitors , Protease Inhibitors/chemistry , Protease Inhibitors/pharmacology , Trypsin Inhibitors/pharmacologyABSTRACT
2-Fluoro- and 2-chloroneplanocin A's (2 and 3) were synthesized as an adenosine deaminase resistant-equivalent of neplanocin A, and evaluated for their antitumor and antiviral activities. Of these, 2 was completely resistant to adenosine deaminase and showed more significant antitumor and antiviral activities than neplanocin A.
Subject(s)
Adenosine Deaminase/metabolism , Adenosine/analogs & derivatives , Antibiotics, Antineoplastic/chemical synthesis , Antiviral Agents/chemical synthesis , Fibrosarcoma/drug therapy , RNA Viruses/drug effects , Adenosine/chemistry , Adenosine/metabolism , Adenosine/pharmacology , Adenosine/therapeutic use , Animals , Antibiotics, Antineoplastic/chemistry , Antibiotics, Antineoplastic/pharmacology , Antibiotics, Antineoplastic/therapeutic use , Antiviral Agents/chemistry , Antiviral Agents/pharmacology , Drug Resistance , Mice , Ribavirin/pharmacologyABSTRACT
To evaluate ras-mediated signal transduction, we constructed a transient transfection assay system that measures chloramphenicol acetyl transferase activity expressed under the transcriptional-enhancer elements responsive to ras, protein kinase C, and protein kinase A in NIH3T3 cells. Characterization of the assay system with several known activators and inhibitors of signal transduction pathways proved that our system could reliably evaluate agents that affect individual pathways. Pirarubicin ((2"R)-4'-tetrahydropyranyladriamycin, THP), which has recently been found able to reverse ras-transformed cells, appeared to selectively inhibit the ras signal transduction pathway.
Subject(s)
Cyclic AMP-Dependent Protein Kinases/metabolism , Enhancer Elements, Genetic/drug effects , Protein Kinase C/metabolism , Signal Transduction/drug effects , Transcription Factors/genetics , ras Proteins/genetics , 3T3 Cells , Animals , Antibiotics, Antineoplastic/pharmacology , Base Sequence , Cell Line, Transformed , Chloramphenicol O-Acetyltransferase/metabolism , Doxorubicin/analogs & derivatives , Doxorubicin/pharmacology , Gene Expression/drug effects , Mice , Molecular Sequence Data , Plasmids , Promoter Regions, Genetic , Signal Transduction/genetics , Transcription Factors/drug effects , Transfection , ras Proteins/drug effects , ras Proteins/metabolismABSTRACT
We developed a new method for evaluating inhibitors of oncogenic signal transduction pathways based on different growth abilities between normal and transformed cells in a defined serum-free medium. The growth rates of src, abl or ras oncogene-transformed cells, activated raf proto-oncogene transformed cells, and normal NIH-3T3 cells were 60-90%, 20-30% and 10% in a serum-free medium, respectively, compared to the growth rates in a serum-containing medium. An addition of a growth factor (PDGF, FGF or TGF-beta) stimulated the growth of normal NIH3T3 cells by 40-80% in a serum-free medium. Herbimycin A, a specific cytoplasmic protein tyrosine kinase inhibitor, selectively inhibited the growth of src or abl transformed cells in the serum-free medium resulting in about 10-fold or fivefold lower IC50 than those in the serum-containing medium. The antibiotic did not show such an effect on ras transformed cells, and the treatment of src transformed cells with other protein kinase inhibitors or cytotoxic drugs showed little IC50 shifts between the two media. Thus, this method of comparing growth inhibition in the serum-free and the serum-containing media may be useful in evaluating specific inhibitors of signaling pathways mediated by growth factors and certain oncogene products.
Subject(s)
Antineoplastic Agents/pharmacology , Cell Transformation, Neoplastic/drug effects , Oncogenes , Protein Kinase Inhibitors , 3T3 Cells , Animals , Benzoquinones , Cell Division/drug effects , Culture Media, Serum-Free , Doxorubicin/pharmacology , Ethylmaleimide/pharmacology , Lactams, Macrocyclic , Mice , Quinones/pharmacology , Rifabutin/analogs & derivatives , Vinblastine/pharmacologySubject(s)
Coproporphyrins/isolation & purification , Photosensitizing Agents/isolation & purification , Porphyrins/isolation & purification , Streptococcus/chemistry , Zinc , Animals , Coproporphyrins/chemistry , Coproporphyrins/pharmacology , Cromolyn Sodium/pharmacology , Hematoporphyrin Photoradiation , Histamine Antagonists/chemistry , Histamine Antagonists/isolation & purification , Histamine Antagonists/pharmacology , Magnetic Resonance Spectroscopy , Male , Mast Cells/drug effects , Mice , Mice, Inbred ICR , Photosensitizing Agents/chemistry , Photosensitizing Agents/pharmacology , Porphyrins/chemistry , Porphyrins/pharmacology , Rats , Sarcoma 180/drug therapy , Spectrophotometry, InfraredABSTRACT
Sporeamicin A, a novel antibiotic, was isolated from the culture filtrate of an actinomycete. The producing organism, strain L53-18, was taxonomically assigned as a species of the genus Saccaropolyspora. The antibiotic was extracted with chloroform and was then purified by crystallization. It was obtained as colorless prisms from ethanolic solutions. Sporeamicin A exhibited a strong UV absorption peak at 276 nm. The molecular formula of sporeamicin A was determined to be C37H63NO12.
Subject(s)
Anti-Bacterial Agents/isolation & purification , Erythromycin/analogs & derivatives , Saccharopolyspora/chemistry , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Erythromycin/chemistry , Erythromycin/isolation & purification , Erythromycin/pharmacology , Gram-Positive Bacteria/drug effects , Microbial Sensitivity Tests , Saccharopolyspora/classificationABSTRACT
Structure of a novel antibiotic, sporeamicin A (SRM-A), was determined by a combination of spectroscopic and X-ray crystallographic studies. SRM-A has a unique structure containing a 2,3-dihydro-3-oxofuran moiety as part of a 14-membered macrolide ring.
Subject(s)
Anti-Bacterial Agents/chemistry , Erythromycin/analogs & derivatives , Erythromycin/chemistry , X-Ray DiffractionABSTRACT
Sporeamicin A is a new erythromycin-type antibiotic isolated from a species of Saccharopolyspora. It was active in vitro against a wide variety of Gram-positive bacteria. In vitro studies indicated that the sporeamicin A was stable in the presence of human serum, although it was bound to serum proteins. Sporeamicin A was effective in the mouse protection test against Staphylococcus aureus, Streptococcus pyogenes and Streptococcus pneumoniae. Sporeamicin A attained higher plasma and tissue levels in the rat than did erythromycin stearate.
Subject(s)
Anti-Bacterial Agents/pharmacology , Erythromycin/analogs & derivatives , Animals , Anti-Bacterial Agents/blood , Anti-Bacterial Agents/pharmacokinetics , Dogs , Erythromycin/blood , Erythromycin/pharmacokinetics , Erythromycin/pharmacology , Gram-Positive Bacteria/drug effects , Humans , Male , Mice , Mice, Inbred ICR , Microbial Sensitivity Tests , Rats , Rats, Inbred Strains , Staphylococcal Infections/prevention & control , Streptococcal Infections/prevention & control , Tissue DistributionABSTRACT
To investigate the nature underlying the process of pattern discrimination learning, a series of seven experiments on seven working assumptions were undertaken. The main findings are as follows. The pattern discrimination learning consists of two time-dependent stages: The initial or first learning stage is the period of performance at chance, and the succeeding or second stage is the period of performance from just above the chance to a criterion level. The duration of the first stage is dependent on the degrees of cue-response separations, whereas that of the second stage is independent of. During the first stage, monkeys do not attend to the discriminative cue even at small cue-response separations, whereas during the second stage, they achieve pattern discrimination, or pattern perception and cognition, regardless of cue-response separations. After having learned the first pattern task with a cue-response separation, they learned new pattern tasks by means of the second stage, showing marked saving of the duration of the first stage. The findings in the present studies indicate that the first stage of learning is predominantly involved in the process of attending to the discriminative cues remote from the response site (a selective attention to the cue), whereas the second stage is concerned with the process of perception and cognition of the discriminative cue.
Subject(s)
Discrimination Learning/physiology , Macaca/physiology , Models, Neurological , Models, Psychological , Pattern Recognition, Visual/physiology , Animals , Attention/physiology , Conditioning, Operant/physiology , Cues , Macaca/psychology , Macaca mulatta/physiology , Macaca mulatta/psychology , Regression Analysis , Time FactorsABSTRACT
New thiol protease inhibitors, estatins A and B, were isolated from the culture filtrate of Myceliophthora thermophila M4323. The basic, water-soluble inhibitors were characterized as having an agmatine, trans-epoxysuccinic acid and L-phenylalanine or L-tyrosine moieties in the structure. The molecular formulas C18H25N5O5 and C18H25N5O6 for A and B were indicated by elemental analysis and fast atom bombardment MS. Estatins were specific inhibitors against thiol proteases such as papain, ficin and bromelain. They suppressed IgE antibody production in mice, but not IgG.